Patents by Inventor Colette Colladant

Colette Colladant has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE PREPARATION OF ECHINOCANDIN DERIVATIVES
    Publication number: 20100273977
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yield of isomer A, and its intended use, e.g. as an antifungal medicament.
    Type: Application
    Filed: July 6, 2010
    Publication date: October 28, 2010
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Crystalline Forms of 3-Beta-Amino 17-Methylene Androstane-6-Alpha 7-Beta-Diol Hydrochloride
    Publication number: 20080051382
    Abstract: The invention relates to novel crystalline forms of 3-beta-amino-17-methylene-androstane-6-alpha,7-beta-diol hydrochloride, referred to as form A, form B and form C, a method for preparing same, the use thereof as a drug, and pharmaceutical compositions containing same.
    Type: Application
    Filed: October 20, 2004
    Publication date: February 28, 2008
    Applicant: INFLAZYME PHARMACEUTICALS LTD.
    Inventors: Colette Colladant, Denis Prat, Pascal Billot, Alexandre Giuliani, Hagit Elnaleh, Marc-Antoine Perrin
  • Process for the preparation of echinocandin derivatives
    Publication number: 20070105760
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yield of isomer A, and its intended use, e.g. as an antifungal medicament.
    Type: Application
    Filed: November 2, 2006
    Publication date: May 10, 2007
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Process for the preparation of echinocandin derivatives
    Patent number: 7148322
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them. The process for preparing formula (I) leads to greater than 50% yields of isomer A, and its intended use, e.g. as an antifungal medicament.
    Type: Grant
    Filed: June 14, 2004
    Date of Patent: December 12, 2006
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof
    Patent number: 7091360
    Abstract: The present invention is directed to a novel process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents that are useful in the synthesis of a variety of pharmaceuticals, in particular certain cysteine protease inhibitors.
    Type: Grant
    Filed: April 16, 2003
    Date of Patent: August 15, 2006
    Assignee: Aventis Pharma S.A.
    Inventors: Jiayao Li, John O. Link, Colette Colladant
  • Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof
    Publication number: 20060135781
    Abstract: The present invention is directed to a novel process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents that are useful in the synthesis of a variety of pharmaceuticals, in particular certain cysteine protease inhibitors.
    Type: Application
    Filed: February 2, 2006
    Publication date: June 22, 2006
    Applicants: Axys Pharmaceuticals, Inc.
    Inventors: Jiayao Li, John Link, Colette Colladant
  • Process for the preparation of echinocandin derivatives
    Publication number: 20050032679
    Abstract: A subject of the invention is a process for the preparation of the compounds of formula (I): R being as defined in the description as well as their salts, the intermediates, the use of the dihydrochloride as a medicament and the pharmaceutical compositions containing them.
    Type: Application
    Filed: June 14, 2004
    Publication date: February 10, 2005
    Applicant: Aventis Pharma S.A.
    Inventors: Philippe Boffelli, Agnes Brouillard, Colette Colladant, Serge Droux, Michel Elter, Didier Ferroud, Guy Lemaitre, Joseph Paladino
  • Process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents and uses thereof
    Publication number: 20040019218
    Abstract: The present invention is directed to a novel process for preparing heteroaryl and unsaturated heterocycloalkylmagnesium reagents that are useful in the synthesis of a variety of pharmaceuticals, in particular certain cysteine protease inhibitors.
    Type: Application
    Filed: April 16, 2003
    Publication date: January 29, 2004
    Applicants: AXYS PHARMACEUTICALS, INC., AVENTIS PHARMACEUTICALS, INC.
    Inventors: Jiayao Li, John O. Link, Colette Colladant
  • Derivatives of octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds
    Publication number: 20030130269
    Abstract: A compound of the formula 1
    Type: Application
    Filed: December 6, 2002
    Publication date: July 10, 2003
    Applicant: Aventis Pharma S.A.
    Inventors: Colette Colladant, Veronique Cro-cq, John Patrick Larkin, Patrick Roussel
  • Derivatives of octahydro-6,10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds
    Patent number: 6570012
    Abstract: Novel intermediates of the formulae where the substituents are defined as in the specification.
    Type: Grant
    Filed: March 20, 2002
    Date of Patent: May 27, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Colette Colladant, Veronique Cro-Cq, John Patrick Larkin, Patrick Roussel
  • Octahydro-6, 10-dioxo-6h-pyridazino/1,2-a/ /1,2/diazepin-1-carboxylic acid, derivatives, preparation method and use for preparing therapeutically active compounds
    Patent number: 6548664
    Abstract: The invention concerns compounds of formula (I) in SR configuration or in the form of a SR+SS mixture, wherein R represents a hydrogen atom, an alkyl or aralkyl radical containing up to 18 carbon atoms, the amine function being free or protected. The compounds can be used for preparing active principles for medicines.
    Type: Grant
    Filed: October 31, 2000
    Date of Patent: April 15, 2003
    Assignee: Aventis Pharma S.A.
    Inventors: Colette Colladant, Veronique Cro-cq, John Patrick Larkin, Patrick Roussel
  • Derivatives of octahydro-6,10-dioxo-6H-pyridazino [1,2-a] [1,2] diazepine-1-carboxylic acid, their preparation process and their use in the preparation of therapeutically active compounds
    Publication number: 20020128473
    Abstract: Novel intermediates of the formulae 1
    Type: Application
    Filed: March 20, 2002
    Publication date: September 12, 2002
    Applicant: Aventis Pharma S.A.
    Inventors: Colette Colladant, Veronique Cro-Cq, John Patrick Larkin, Patrick Roussel
  • Method for preparing alkyloxy furanone derivatives, compounds obtained by said method and use of said compounds
    Patent number: 6235899
    Abstract: The invention relates to a novel process for preparing compounds of the formula (IV) or (I): from the racemic alkoxyfuranone of the formula (II): R1 and R2 being as defined in the description, to the novel compounds of the formula (IV) as well as to the intermediate compounds of this process, and to the use of the compounds of the formula (IV) or (I) in the process for the synthesis of compounds which inhibit interleukin-1beta converting enzyme.
    Type: Grant
    Filed: February 1, 2000
    Date of Patent: May 22, 2001
    Assignee: Hoechst Marion Roussel
    Inventors: Raphael Bouchet, Francis Brion, Colette Colladant, Jacques Lagouardat
  • Process and intermediates
    Patent number: 5312964
    Abstract: A novel process for the preparation of isomers or mixtures of isomers of compounds of the formula ##STR1## and novel intermediates therefore.
    Type: Grant
    Filed: May 27, 1993
    Date of Patent: May 17, 1994
    Assignee: Roussel UCLAF
    Inventors: Didier Babin, Neerja Bhatnagar, Francis Brion, Colette Colladant
  • Process
    Patent number: 5278322
    Abstract: A process for the preparation of a compound of the formula ##STR1## comprising reacting 1R, cis 2,2-dimethyl 3-(2-oxopropyl)-cyclopropane-1-carboxylic acid with an alkali metal, alkaline-earth metal or magnesium hypohalite, and oxidizing the 1R, cis 2,2-dimethyl 3-(hydroxy-carboxy-methyl)-cyclopropane-1-carboxylic acid or its salt or lactonic form thereof thus obtained with an oxidizing agent to obtain the compound of formula I and novel intermediates.
    Type: Grant
    Filed: October 29, 1992
    Date of Patent: January 11, 1994
    Assignee: Roussel Uclaf
    Inventors: Francis Brion, Colette Colladant, Jacques Lagouardat, Jacques Scholl
  • Process for the preparation of the lactone of 1R, cis 2,2-dimethyl-3-formyl-cyclopropane-1-carboxylic acid
    Patent number: 5276167
    Abstract: A process for preparation of a compound of the formula ##STR1##
    Type: Grant
    Filed: October 21, 1992
    Date of Patent: January 4, 1994
    Assignee: Roussel Uclaf
    Inventors: Neerja Bhatnagar, Francois Brion, Colette Colladant